Nelarabine-induced rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia: a case report

Nelarabine-induced rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia: a case report

Abstract Background Nelarabine is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL). The most prominent side effect of nelarabine are neurotoxicity and hematologic disorder, which are considered dose-limiting factors. Althoug...

Full description

Bibliographic Details
Main Authors: Akari Utsumi, Yuri Goto, Takaaki Suzuki, Chiaki Imai, Shinichiro Matsui, Emiko Sakaida, Itsuko Ishii
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Rhabdomyolysis
Nelarabine
Creatine kinase
Online Access:https://doi.org/10.1186/s40780-022-00247-w

Internet

https://doi.org/10.1186/s40780-022-00247-w

Similar Items